Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.
Valderrama-Treviño AI, Barrera-Mera B, Ceballos-Villalva JC, Montalvo-Javé EE. Hepatic metastasis from colorectal cancer. Euroasian J Hepatogastroenterol. 2017;7(2):166–75. https://doi.org/10.5005/jp-journals-10018-1241.
Article PubMed PubMed Central Google Scholar
McNally SJ, Parks RW. Surgery for colorectal liver metastases. Dig Surg. 2013;30(4–6):337–47. https://doi.org/10.1159/000351442.
Article CAS PubMed Google Scholar
Akgül Ö, Çetinkaya E, Ersöz Ş, Tez M. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol. 2014;20(20):6113–22. https://doi.org/10.3748/wjg.v20.i20.6113.
Article PubMed PubMed Central Google Scholar
Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases—a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78. https://doi.org/10.1186/s12885-017-3925-x.
Article PubMed PubMed Central Google Scholar
Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–26. https://doi.org/10.1002/cncr.22448.
Petre EN, Sofocleous C. Thermal ablation in the management of colorectal cancer patients with oligometastatic liver disease. Visc Med. 2017;33(1):62–8. https://doi.org/10.1159/000454697.
Article PubMed PubMed Central Google Scholar
Takahashi H, Berber E. Role of thermal ablation in the management of colorectal liver metastasis. Hepatobiliary Surg Nutr. 2020;9(1):49–58. https://doi.org/10.21037/hbsn.2019.06.08.
Article PubMed PubMed Central Google Scholar
Puijk RS, Dijkstra M, van den Bemd BAT, Ruarus AH, Nieuwenhuizen S, Geboers B, et al. Improved outcomes of thermal ablation for colorectal liver metastases: a 10-year analysis from the prospective amsterdam CORE registry (AmCORE). Cardiovasc Intervent Radiol. 2022;45(8):1074–89. https://doi.org/10.1007/s00270-022-03152-9.
Article PubMed PubMed Central Google Scholar
Meijerink MR, Puijk RS, van Tilborg AAJM, Henningsen KH, Fernandez LG, Neyt M, et al. Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2018;41(8):1189–204. https://doi.org/10.1007/s00270-018-1959-3.
Article PubMed PubMed Central Google Scholar
Ruers T, Van Coevorden F, Punt CJ, et al. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017. https://doi.org/10.1093/jnci/djx015.
Article PubMed PubMed Central Google Scholar
Puijk RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, Scheffer HJ, Nielsen K, et al. COLLISION Trial Group .Colorectal liver metastases: surgery versus thermal ablation (COLLISION)—a phase III single-blind prospective randomized controlled trial. BMC Cancer. 2018;18(1):821. https://doi.org/10.1186/s12885-018-4716-8.
Article PubMed PubMed Central Google Scholar
Meijerink MR, Puijk RS, van den Tol PMP. COLLISION trial seeks to answer time-honored question: “thermal ablation or surgery for colorectal liver metastases?” Cardiovasc Intervent Radiol. 2019;42(8):1059–61. https://doi.org/10.1007/s00270-019-02236-3.
De Cobelli F, Della CA. Thermal ablation for colorectal liver metastases: the time has come. Cardiovasc Intervent Radiol. 2022;45:1090–1. https://doi.org/10.1007/s00270-022-03198-9.
van Amerongen MJ, Jenniskens SFM, van den Boezem PB, Fütterer JJ, de Wilt JHW. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases—a meta-analysis. HPB (Oxford). 2017;19(9):749–56. https://doi.org/10.1016/j.hpb.2017.05.011.
Wang LJ, Zhang ZY, Yan XL, Yang W, Yan K, Xing BC. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis. World J Surg Oncol. 2018;16(1):207. https://doi.org/10.1186/s12957-018-1494-3.
Article PubMed PubMed Central Google Scholar
Takahashi H, Kahramangil B, Berber E. Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series. Surgery. 2018;163(4):709–13.
Abreu de Carvalho LF, Logghe B, Van Cleven S, Vanlander A, Moura Ribeiro S, Geboes K, et al. Local control of hepatocellular carcinoma and colorectal liver metastases after surgical microwave ablation without concomitant hepatectomy. Langenbecks Arch Surg. 2021;406(8):2749–57. https://doi.org/10.1007/s00423-021-02219-4.
Puijk RS, Ahmed M, Adam A, Arai Y, Arellano R, de Baère T, et al. Consensus Guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533–40. https://doi.org/10.1148/radiol.2021203715.
Rompianesi G, Pegoraro F, Ceresa CD, Montalti R, Troisi RI. Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases. World J Gastroenterol. 2022;28(1):108–22. https://doi.org/10.3748/wjg.v28.i1.108.
Article CAS PubMed PubMed Central Google Scholar
Taghavi M, Staal F, Gomez Munoz F, Imani F, Meek DB, et al. CT-based radiomics analysis before thermal ablation to predict local tumor progression for colorectal liver metastases. Cardiovasc Intervent Radiol. 2021;44(6):913–20. https://doi.org/10.1007/s00270-020-02735-8.
Staal FCR, Taghavi M, van der Reijd DJ, Gomez FM, Imani F, Klompenhouwer EG, et al. Predicting local tumour progression after ablation for colorectal liver metastases: CT-based radiomics of the ablation zone. Eur J Radiol. 2021;141:109773. https://doi.org/10.1016/j.ejrad.2021.109773.
Article CAS PubMed Google Scholar
Nieuwenhuizen S, Puijk RS, van den Bemd B, Aldrighetti L, Arntz M, van den Boezem PB, et al. Resectability and ablatability criteria for the treatment of liver only colorectal metastases: multidisciplinary consensus document from the COLLISION Trial Group. Cancers (Basel). 2020;12(7):1779. https://doi.org/10.3390/cancers12071779.
Article CAS PubMed Google Scholar
Crocetti L, de Baére T, Pereira PL, Tarantino FP. CIRSE standards of practice on thermal ablation of liver tumours. Cardiovasc Intervent Radiol. 2020;43(7):951–62. https://doi.org/10.1007/s00270-020-02471-z.
Tibshirani R. Regression shrinkage and selection via the lasso. J R Statl Soc. 1996;58(1):267–88.
Unal I. Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med. 2017;2017:3762651. https://doi.org/10.1155/2017/3762651.
Article PubMed PubMed Central Google Scholar
Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–72. https://doi.org/10.1002/sim.2929.
Qin S, Liu GJ, Huang M, Huang J, Luo Y, Wen Y, et al. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center. Int J Hyperthermia. 2019;36(1):36–43. https://doi.org/10.1080/02656736.2018.1528511.
Mimmo A, Pegoraro F, Rhaiem R, Montalti R, Donadieu A, Tashkandi A, et al. Microwave ablation for colorectal liver metastases: a systematic review and pooled oncological analyses. Cancers (Basel). 2022;14(5):1305. https://doi.org/10.3390/cancers14051305.
Knott EA, Ziemlewicz TJ, Lubner SJ, Swietlik JF, Weber SM, Zlevor AM, et al. Microwave ablation for colorectal cancer metastasis to the liver: a single-center retrospective analysis. J Gastrointest Oncol. 2021;12(4):1454–69. https://doi.org/10.21037/jgo-21-159.
Article PubMed PubMed Central Google Scholar
Vogl TJ, Zitsch M, Albrecht M, D’Angelo T, Basten L, Gruber-Rouh T, et al. Long-term outcomes following percutaneous microwave ablation for colorectal cancer liver metastases. Int J Hyperthermia. 2022;39(1):788–95. https://doi.org/10.1080/02656736.2022.2077991.
Article CAS PubMed Google Scholar
Urbonas T, Anderson EM, Gordon-Weeks AN, Kabir SI, Soonawalla Z, Silva MA, et al. (2019) Factors predicting ablation site recurrence following percutaneous microwave ablation of colorectal hepatic metastases. HPB (Oxford).21(9): 1175–1184. doi: https://doi.org/10.1016/j.hpb.2019.01.007.
van Dam PJ, van der Stok EP, Teuwen LA, Van den Eynden GG, Illemann M, Frentzas S, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br J Cancer. 2017;117(10):1427–41. https://doi.org/10.1038/bjc.2017.334.
Article PubMed PubMed Central Google Scholar
Kong BT, Fan QS, Wang XM, Zhang Q, Zhang GL. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases. World J Gastroenterol. 2022;28(26):3101–15. https://doi.org/10.3748/wjg.v28.i26.3101.
Article CAS PubMed PubMed Central Google Scholar
Peng S, Huang P, Yu H, Wen Y, Luo Y, Wang X, et al. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance. Medicine (Baltimore). 2018; 97(10): e0044. doi: https://doi.org/10.1097/MD.0000000000010044.
Cho JY, Lee YJ, Han HS, Yoon YS, Kim J, Choi Y, et al. Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer. World J Surg. 2015;39(5):1161–6. https://doi.org/10.1007/s00268-015-2944-5.
留言 (0)